Quest Diagnostics Inc. (DGX) SVP & CFO Robert Hagemann sells 113,334 Shares

SVP & CFO of Quest Diagnostics Inc. (DGX) Robert Hagemann sells 113,334 shares of DGX on 01/26/2012 at an average price of $59.15 a share.

Quest Diagnostics Inc. has a market cap of $9.31 billion; its shares were traded at around $59 with a P/E ratio of 13.02 and P/S ratio of 1.24. The dividend yield of Quest Diagnostics Inc. stocks is 1.15%. Quest Diagnostics Inc. had an annual average earning growth of 13.2% over the past 10 years. GuruFocus rated Quest Diagnostics Inc. the business predictability rank of 4.5-star.

This is the annual revenues and earnings per share of DGX over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of DGX.

CEO Recent Trades:

• Chairman, President & CEO Surya N Mohapatra sold 20,556 shares of DGX stock on 01/03/2012 at the average price of 58.66. Surya N Mohapatra owns at least 362,641 shares after this. The price of the stock has increased by 0.58% since.
• Chairman, President & CEO Surya N Mohapatra sold 20,556 shares of DGX stock on 12/01/2011 at the average price of 57.95. Surya N Mohapatra owns at least 362,642 shares after this. The price of the stock has increased by 1.81% since.
• Chairman, President & CEO Surya N Mohapatra sold 20,556 shares of DGX stock on 11/01/2011 at the average price of 54.69. Surya N Mohapatra owns at least 362,645 shares after this. The price of the stock has increased by 7.88% since.
• Chairman, President & CEO Surya N Mohapatra sold 50,000 shares of DGX stock on 10/28/2011 at the average price of 57.41. Surya N Mohapatra owns at least 362,642 shares after this. The price of the stock has increased by 2.77% since.
• Chairman, President & CEO Surya N Mohapatra sold 48,047 shares of DGX stock on 10/25/2011 at the average price of 56.49. Surya N Mohapatra owns at least 362,643 shares after this. The price of the stock has increased by 4.44% since.

CFO Recent Trades:

• SVP & CFO Robert Hagemann sold 4,150 shares of DGX stock on 12/21/2011 at the average price of 57.75. Robert Hagemann owns at least 141,442 shares after this. The price of the stock has increased by 2.16% since.
• SVP & CFO Robert Hagemann sold 4,150 shares of DGX stock on 12/01/2011 at the average price of 58.15. Robert Hagemann owns at least 141,443 shares after this. The price of the stock has increased by 1.46% since.
• SVP & CFO Robert Hagemann sold 4,150 shares of DGX stock on 11/21/2011 at the average price of 54.4. Robert Hagemann owns at least 141,443 shares after this. The price of the stock has increased by 8.46% since.
• SVP & CFO Robert Hagemann sold 4,150 shares of DGX stock on 11/01/2011 at the average price of 54.8. Robert Hagemann owns at least 141,443 shares after this. The price of the stock has increased by 7.66% since.
• SVP & CFO Robert Hagemann sold 4,150 shares of DGX stock on 10/21/2011 at the average price of 49.29. Robert Hagemann owns at least 141,429 shares after this. The price of the stock has increased by 19.7% since.

This is the insider trade history vs. stock price of DGX. For the complete insider trading history of DGX, click here.

Directors and Officers Recent Trades:

• VP and Corporate Controller Thomas F Bongiorno sold 13,334 shares of DGX stock on 11/08/2011 at the average price of 57.5. Thomas F Bongiorno owns at least 20,448 shares after this. The price of the stock has increased by 2.61% since.
• Director Jenne K Britell sold 7,500 shares of DGX stock on 11/03/2011 at the average price of 55.7. Jenne K Britell owns at least 12,477 shares after this. The price of the stock has increased by 5.92% since.
• Director John B Ziegler sold 12,997 shares of DGX stock on 10/28/2011 at the average price of 57.28. John B Ziegler owns at least 18,679 shares after this. The price of the stock has increased by 3% since.
• SVP-Oncology & Neurology Srvcs Joan Elizabeth Miller sold 19,259 shares of DGX stock on 10/28/2011 at the average price of 57.5. Joan Elizabeth Miller owns at least 78,783 shares after this. The price of the stock has increased by 2.61% since.
• SVP & General Counsel Michael E Prevoznik sold 116,000 shares of DGX stock on 10/27/2011 at the average price of 56.68. Michael E Prevoznik owns at least 45,390 shares after this. The price of the stock has increased by 4.09% since.

For the complete insider trading history of DGX, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool